Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055 · see citing works

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742 · see citing works

VSEARCH: a versatile open source tool for metagenomics

(2016) · doi:10.7717/peerj.2584 · Cited by 10,773 · see citing works

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116 · see citing works

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · see citing works

PEAR: a fast and accurate Illumina Paired-End reAd mergeR

Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497 · see citing works

Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works

Host microbiota constantly control maturation and function of microglia in the CNS

Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

The prevalence of Parkinson's disease: a systematic review and meta-analysis

Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188 · see citing works

Gut microbiota are related to Parkinson's disease and clinical phenotype

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works

Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns

Amir, A., McDonald, D., Navas-Molina, J. A., Kopylova, E., Morton, J. T., Zech Xu, Z., Kightley, E. P., Thompson, L. R., Hyde, E. R., Gonzalez, A., et al. (2017) · mSystems · doi:10.1128/msystems.00191-16 · Cited by 1,881 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · see citing works

The yin and yang of neurotrophin action

Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356 · see citing works

Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway

Park, J., Kim, M., Kang, S. G., Jannasch, A. H., Cooper, B., Patterson, J., & Kim, C. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.44 · Cited by 1,307 · see citing works

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289 · see citing works

Psychobiotics: A novel class of psychotropic

Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287 · see citing works

Colonic bacterial composition in Parkinson's disease

Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · see citing works

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161 · see citing works

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · see citing works

Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain

Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,087 · see citing works

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,046 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases

Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,003 · see citing works

Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986 · see citing works

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974 · see citing works

Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial

Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946 · see citing works

Oxidative stress and Parkinson’s disease

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878 · see citing works

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · see citing works

Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · see citing works

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

Duty, S., & Jenner, P. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 758 · see citing works

Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway

Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · see citing works

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · see citing works

EPA-ng: Massively Parallel Evolutionary Placement of Genetic Sequences

Barbera, P., Kozlov, A. M., Czech, L., Morel, B., Darriba, D., Flouri, T., & Stamatakis, A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy054 · Cited by 695 · see citing works

A Parsimony Approach to Biological Pathway Reconstruction/Inference for Genomes and Metagenomes

Ye, Y., & Doak, T. G. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000465 · Cited by 680 · see citing works

Altered Microbiomes Distinguish Alzheimer’s Disease from Amnestic Mild Cognitive Impairment and Health in a Chinese Cohort

Liu, P., Wu, L., Peng, G., Han, Y., Tang, R., Ge, J., Zhang, L., Jia, L., Yue, S., Zhou, K., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.008 · Cited by 669 · see citing works

A rotarod test for evaluation of motor skill learning

Shiotsuki, H., Yoshimi, K., Shimo, Y., Funayama, M., Takamatsu, Y., Ikeda, K., Takahashi, R., Kitazawa, S., & Hattori, N. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.03.026 · Cited by 627 · see citing works

Nitric oxide synthase and neuronal vulnerability in parkinson's disease

Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595 · see citing works

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 591 · see citing works

Brain-Gut-Microbiota Axis in Parkinson’s Disease

Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583 · see citing works

Efficient comparative phylogenetics on large trees

Louca, S., & Doebeli, M. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx701 · Cited by 564 · see citing works

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

Nuytemans, K., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 560 · see citing works

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 559 · see citing works

Neural regulation of immunity: molecular mechanisms and clinical translation

Pavlov, V. A., & Tracey, K. J. (2017) · Nature Neuroscience · doi:10.1038/nn.4477 · Cited by 534 · see citing works

Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats

Soret, R., Chevalier, J., De Coppet, P., Poupeau, G., Derkinderen, P., Segain, J. P., & Neunlist, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.053 · Cited by 530 · see citing works

Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease

Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · see citing works

Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2

Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · see citing works

Protective and toxic roles of dopamine in Parkinson's disease

Segura‐Aguilar, J., Paris, I. B., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 499 · see citing works

MPTP Mouse Models of Parkinson’s Disease: An Update

Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11023 · Cited by 471 · see citing works

Glutathione metabolism and Parkinson's disease

Smeyne, M., & Smeyne, R. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.001 · Cited by 436 · see citing works

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

Mittal, S., Bjørnevik, K., Im, D. S., Flierl, A., Dong, X., Locascio, J. J., Abo, K. M., Long, E., Jin, M., Xu, B. Y., et al. (2017) · Science · doi:10.1126/science.aaf3934 · Cited by 417 · see citing works

Genesis and Gappa: processing, analyzing and visualizing phylogenetic (placement) data

Czech, L., Barbera, P., & Stamatakis, A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa070 · Cited by 417 · see citing works

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405 · see citing works

Steroid hormone receptor expression and function in microglia

Sierra, A., Gottfried‐Blackmore, A., Milner, T. A., McEwen, B. S., & Bulloch, K. (2008) · Glia · doi:10.1002/glia.20644 · Cited by 405 · see citing works

Assessment of Motor Balance and Coordination in Mice using the Balance Beam

Luong, T. N., Carlisle, H. J., Southwell, A. L., & Patterson, P. H. (2011) · Journal of Visualized Experiments · doi:10.3791/2376 · Cited by 401 · see citing works

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392 · see citing works

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

Pearce, R. K. B., Owen, A., Daniel, S. E., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350 · see citing works

A simple quantitative bradykinesia test in MPTP-treated mice.

Ogawa, N., Hirose, Y., Ohara, S., Ono, T., & Watanabe, Y. (1985) · PubMed · Cited by 334 · see citing works

NGF and Its Receptors in the Regulation of Inflammatory Response

Minnone, G., Benedetti, F. D., & Bracci‐Laudiero, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051028 · Cited by 322 · see citing works

Twenty-Four Hour Cortisol Release Profiles in Patients With Alzheimer's and Parkinson's Disease Compared to Normal Controls: Ultradian Secretory Pulsatility and Diurnal Variation

Hartmann, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80309-0 · Cited by 319 · see citing works

Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

Baquet, Z., Bickford, P., & Jones, K. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4601-04.2005 · Cited by 301 · see citing works

Gastrointestinal dysfunction in Parkinson's disease

Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298 · see citing works

Chronic stress and glucocorticoids: From neuronal plasticity to neurodegeneration

Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Almeida, O. F. X., Sousa, N., & Sotiropoulos, I. (2016) · Neural Plasticity · doi:10.1155/2016/6391686 · Cited by 297 · see citing works

Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples

Garcı́a-Villalba, R., Giménez‐Bastida, J. A., García‐Conesa, M., Tomás-Barberán, F. A., Espı́n, J. C., & Larrosa, M. (2012) · Journal of Separation Science · doi:10.1002/jssc.201101121 · Cited by 291 · see citing works

Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice

Liu, Y.-W., Liu, W., Wu, C.-C., Juan, Y.-C., Wu, Y.-C., Tsai, H.-P., Wang, S. Z., & Tsai, Y.-C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.018 · Cited by 290 · see citing works

Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,

Mischoulon, D., & Fava, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1158s · Cited by 285 · see citing works

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease

Cersosimo, M. G., & Benarroch, E. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 284 · see citing works

Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids

Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., & Salminen, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705682 · Cited by 274 · see citing works

Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice

Liu, W.-H., Chuang, H.-L., Huang, Y.-T., Wu, C.-C., Chou, G.-T., Wang, S., & Tsai, Y.-C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.046 · Cited by 269 · see citing works

Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study

Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J. M. (2018) · Current Alzheimer Research · doi:10.2174/1389200219666180813144834 · Cited by 269 · see citing works

Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial

Liu, Y.-W., Liong, M., Chung, Y.-C. E., Huang, H.-Y., Peng, W.-S., Cheng, Y.-F., Lin, Y.-S., Wu, Y., & Tsai, Y.-C. (2019) · Nutrients · doi:10.3390/nu11040820 · Cited by 264 · see citing works

A probiotic modulates the microbiome and immunity in multiple sclerosis

Tankou, S. K., Regev, K., Healy, B. C., Tjon, E. C., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 263 · see citing works

Establishment of an Analytical System for the Human Fecal Microbiota, Based on Reverse Transcription-Quantitative PCR Targeting of Multicopy rRNA Molecules

Matsuda, K., Tsuji, H., Asahara, T., Matsumoto, K., Takada, T., & Nomoto, K. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01843-08 · Cited by 262 · see citing works

Caudo‐rostral brain spreading of α‐synuclein through vagal connections

Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250 · see citing works

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study

Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187307 · Cited by 248 · see citing works

Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease

ANDERSON, G., Noorian, A. R., Taylor, G. T., Anitha, M., BERNHARD, D., SRINIVASAN, S., & GREENE, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.010 · Cited by 238 · see citing works

Gut Dysbiosis in Patients with Anorexia Nervosa

Morita, C., Tsuji, H., Hata, T., Gondo, M., Takakura, S., Kawai, K., Yoshihara, K., Ogata, K., Nomoto, K., Miyazaki, K., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145274 · Cited by 238 · see citing works

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application

Xu, L., & Pu, J. (2016) · Parkinson s Disease · doi:10.1155/2016/1720621 · Cited by 237 · see citing works

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · see citing works

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice

Sriram, K., Pai, K. S., Boyd, M. R., & Ravindranath, V. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01271-1 · Cited by 226 · see citing works

Stress, depression and Parkinson's disease

Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225 · see citing works

Dysbiosis of gut microbiota in a selected population of Parkinson's patients

Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N. B., Biocca, S., Stefani, A., & Desideri, A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.003 · Cited by 217 · see citing works

Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,

Mischoulon, D., & Fava, M. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76/5.1158s · Cited by 212 · see citing works

Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity

Srivastav, S., Neupane, S., Bhurtel, S., Katila, N., Maharjan, S., Choi, H., Hong, J. T., & Choi, D.-Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.021 · Cited by 212 · see citing works

Untitled work

(2011) · PubMed · Cited by 207 · see citing works

NGF, BDNF, NT3, and NT4

Bothwell, M. A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_1 · Cited by 205 · see citing works

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms

Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · see citing works

Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions.

Hempstead, B. L. (2015) · Europe PMC (PubMed Central) · Cited by 203 · see citing works

The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies

Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203 · cited 1× · see citing works

Nigral and extranigral pathology in Parkinson's disease.

Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198 · see citing works

Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation

Park, J., Wang, Q., Wu, Q., Mao‐Draayer, Y., & Kim, C. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-45311-y · Cited by 197 · see citing works

Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites

Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195 · see citing works

Lipopolysaccharide Animal Models for Parkinson's Disease

Liu, M., & Bing, G. (2011) · Parkinson s Disease · doi:10.4061/2011/327089 · Cited by 191 · see citing works

Gut Microbiota and Brain Function: An Evolving Field in Neuroscience: Table 1.

Foster, J. A., Lyte, M., Meyer, E., & Cryan, J. F. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv114 · Cited by 188 · see citing works

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice

Rommelfanger, K. S., Edwards, G. L., Freeman, K. G., Liles, L. C., Miller, G. W., & Weinshenker, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702753104 · Cited by 184 · see citing works

Altered gut microbiome in parkinson’s disease and the influence of lipopolysaccharide in a human α-synuclein over-expressing mouse model

Gorecki, A. M., Preskey, L., Bakeberg, M. C., Kenna, J. E., Gildenhuys, C., MacDougall, G., Dunlop, S. A., Mastaglia, F. L., Akkari, P. A., Koengten, F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00839 · Cited by 184 · see citing works

Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus

Frank, M. G., Hershman, S. A., Weber, M. D., Watkins, L. R., & Maier, S. F. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.006 · Cited by 183 · see citing works

Reduced intravenous glutathione in the treatment of early parkinson's disease

Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173 · see citing works

Parkinson’s Disease and the Gastrointestinal Microbiome

Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172 · see citing works

Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria

Jansen, G. J., Wildeboer-Veloo, A. C. M., Tonk, R. H. J., Franks, A. H., & Welling, G. W. (1999) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(99)00049-4 · Cited by 170 · see citing works

Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice

Choi, J. G., Kim, N., Ju, I. G., Eo, H., Lim, S.-M., Jang, S.-E., Kim, D.-H., & Oh, M. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-19646-x · Cited by 170 · see citing works

Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

Lai, F., Jiang, R., Xie, W., Liu, X., Tang, Y., Xiao, H., Gao, J., Jia, Y., & Bai, Q. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2620-x · Cited by 169 · see citing works

S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders

Sharma, A. K., Gerbarg, P. L., Bottiglieri, T., Massoumi, L., Carpenter, L. L., Lavretsky, H., Muskin, P. R., Brown, R. P., & Mischoulon, D. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16r11113 · Cited by 158 · see citing works

Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review

Nair, A. T., Ramachandran, V., Joghee, N. M., Shanish Antony, A., & Ramalingam, G. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17105 · Cited by 156 · see citing works

The Beneficial Effects of Lactobacillus plantarum PS128 on High-Intensity, Exercise-Induced Oxidative Stress, Inflammation, and Performance in Triathletes

Huang, W.-C., Wei, C., Huang, C.-C., Chen, W., & Huang, H.-Y. (2019) · Nutrients · doi:10.3390/nu11020353 · Cited by 155 · see citing works

Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity

Counts, S., & Mufson, E. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06622.x · Cited by 154 · see citing works

Expression pattern and localization of alpha-synuclein in the human enteric nervous system

Bottner, M. B., Zorenkov, D., Hellwig, I., Barrenschee, M., Harde, J., Fricke, T., Deuschl, G., Egberts, J. D., Becker, T., Fritscher‐Ravens, A., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.018 · Cited by 139 · see citing works

Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production.

Russo, C. D., Boullerne, A. I., Gavrilyuk, V., & Feinstein, D. L. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-9 · Cited by 137 · see citing works

Enteric alpha‐synuclein expression is increased in <scp>P</scp>arkinson's disease but not <scp>A</scp>lzheimer's disease

Gold, A., Turkalp, Z. T., & Munoz, D. G. (2013) · Movement Disorders · doi:10.1002/mds.25298 · Cited by 132 · see citing works

Recent advances in understanding neurotrophin signaling

Bothwell, M. A. (2016) · F1000Research · doi:10.12688/f1000research.8434.1 · Cited by 130 · see citing works

Noradrenergic stimulation of BDNF synthesis in astrocytes: Mediation via α1- and β1/β2-adrenergic receptors

Jurič, D. M., Lončar, D., & Čarman‐Kržan, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.035 · Cited by 108 · see citing works

Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems

Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., & Pinnen, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/240146 · Cited by 106 · see citing works

Antioxidative and Anti-Inflammatory Protection from Carnosine in the Striatum of MPTP-Treated Mice

Tsai, S.-J., Kuo, W., Liu, W., & Yin, M. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103258p · Cited by 101 · see citing works

Cortisol is higher in parkinsonism and associated with gait deficit

Charlett, A., Dobbs, R. J., Purkiss, A. G., Wrighe, D. J., Peterson, D. W., Weller, C., & Dobbs, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00614.x · Cited by 98 · see citing works

Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice

Marien, M. R., Briley, M., & Colpaert, F. C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90489-5 · Cited by 92 · see citing works

Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol

Khan, M. M., Kempuraj, D., Thangavel, R., & Zaheer, A. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.029 · Cited by 88 · see citing works

Traumatic Brain Injury Alters Methionine Metabolism: Implications for Pathophysiology

Dash, P. K., Hergenroeder, G. W., Jeter, C. B., Choi, H. A., Kobori, N., & Moore, A. N. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00036 · Cited by 81 · see citing works

Nerve Growth Factor Rapidly Induces Prolonged Acetylcholine Release from Cultured Basal Forebrain Neurons: Differentiation between Neuromodulatory and Neurotrophic Influences

Auld, D. S., Mennicken, F., & Quirion, R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03375.2001 · Cited by 77 · see citing works

Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation

Rokad, D., Ghaisas, S., Harischandra, D. S., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.12.003 · Cited by 75 · see citing works

The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains

Yasuda, Y. U., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Yagi, K., Suzuki, K., & Fujita, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.003 · Cited by 73 · see citing works

Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1

Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72 · see citing works

Lactobacillus plantarum PS128 ameliorates 2,5-Dimethoxy-4-iodoamphetamine-induced tic-like behaviors via its influences on the microbiota–gut-brain-axis

Liao, J.-F., Cheng, Y.-F., Li, S.-W., Lee, W., Hsu, C.-C., Wu, C.-C., Jeng, O.-J., Wang, S. Z., & Tsai, Y.-C. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.027 · Cited by 59 · see citing works

Neuroprotective effect of naringenin against MPTP-induced oxidative stress

Sugumar, M., Sevanan, M., & Sekar, S. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1545772 · Cited by 56 · see citing works

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour

Djamshidian, A., O’Sullivan, S. S., Papadopoulos, A. S., Bassett, P., Shaw, K., Averbeck, B. B., & Lees, A. J. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.245746 · Cited by 55 · see citing works

Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators

Hinojosa, A. E., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-81 · Cited by 34 · see citing works

Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson’s disease: Involvement of the dopamine system

Guo, Z., Xu, S., Du, N., Jia Liu, B., Huang, Y. H., & Han, M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.048 · Cited by 33 · see citing works

S‐Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders

Kuželički, N. K. (2016) · Drug Development Research · doi:10.1002/ddr.21345 · Cited by 29 · see citing works

Elevation Of Striatal Interleukin‐6 and Serum Corticosterone Contents In Mptp‐Treated Mice

Kaku, K., Shikimi, T., Kamisaki, Y., Shinozuka, K., Ishino, H., Okunishi, H., & Takaori, S. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03113.x · Cited by 24 · see citing works

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies

Trošt, M., Perovnik, M., & Pirtošek, Z. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01204 · Cited by 20 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling

Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A. S., & Covașă, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 316 · see citing works

<i>Lactobacillus plantarum</i> DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson’s Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder

Wang, L., Zhao, Z., Zhao, L., Zhao, Y., Yang, G., Wang, C., Gao, L., Niu, C., & Li, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07711 · Cited by 203 · see citing works

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177 · see citing works

The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota

Tang, H., Huang, W., & Yao, Y. (2023) · Microbial Cell · doi:10.15698/mic2023.03.792 · Cited by 169 · see citing works

Short-chain fatty acids-producing probiotics: A novel source of psychobiotics

Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 155 · see citing works

Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease

Cui, C., Han, Y., Li, H., Yu, H., Zhang, B., & Li, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.887407 · Cited by 110 · see citing works

Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders

Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02053-3 · Cited by 105 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

The Add-On Effect of Lactobacillus plantarum PS128 in Patients With Parkinson's Disease: A Pilot Study

Lu, C., Chang, H., Weng, Y.-H., Chen, C.-C., Kuo, Y.-S., & Tsai, Y.-C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.650053 · Cited by 80 · see citing works

Polymannuronic Acid Prebiotic plus Lacticaseibacillus Rhamnosus GG Probiotic as a Novel Synbiotic Promoted Their Separate Neuroprotection against Parkinson’s Disease

Liu, X., Du, Z. R., Wang, X., Sun, X. R., Zhao, Q., Zhao, F., Wong, W. T., Wong, K. H., & Dong, X.-L. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111067 · Cited by 77 · see citing works

Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence

Leta, V., Chaudhuri, К. R., Milner, O., Chung‐Faye, G., Metta, V., Pariante, C. M., & Borsini, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.026 · Cited by 77 · see citing works

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease

Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76 · see citing works

Lactobacillus rhamnosus GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood

Zhou, B., Jin, G., Pang, X., Mo, Q., Bao, J., Liu, T., Wu, J., Xie, R., Liu, X., Liu, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106090 · Cited by 77 · see citing works

Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis

Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Nutrients · doi:10.3390/nu15071737 · Cited by 71 · see citing works

Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)

Lei, Q., Wu, T., Wu, J., Hu, X., Guan, Y., Wang, Y., Yan, J., & Shi, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12374 · Cited by 70 · see citing works

Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer’s Disease-Related Pathologies in Wild-Type Mice

Abdelhamid, M., Zhou, C., Jung, C., & Michikawa, M. (2022) · Nutrients · doi:10.3390/nu14122543 · Cited by 68 · see citing works

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease

Chen, T.-J., Feng, Y., Liu, T., Wu, T.-T., Chen, Y.-J., Li, X., Li, Q., & Wu, Y.-C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549037 · Cited by 69 · see citing works

Bacterial Extracellular Vesicles and the Gut‐Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics

Pirolli, N. H., Bentley, W. E., & Jay, S. M. (2021) · Advanced Biology · doi:10.1002/adbi.202000540 · Cited by 70 · see citing works

New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota

Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69 · see citing works

Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis

Huang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh‐Li, H. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03426-8 · Cited by 64 · see citing works

Lactobacillus plantarum PS128 Promotes Intestinal Motility, Mucin Production, and Serotonin Signaling in Mice

Chen, C.-M., Wu, C.-C., Huang, C.-L., Chang, M.-Y., Cheng, S.-H., Lin, C.-T., & Tsai, Y.-C. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09814-3 · Cited by 67 · see citing works

Lactobacillus paracasei PS23 improves cognitive deficits via modulating the hippocampal gene expression and the gut microbiota in d -galactose-induced aging mice

Cheng, L., Chou, P.-Y., Hou, A.-T., Huang, C.-L., Shiu, W.-L., & Wang, S. (2022) · Food & Function · doi:10.1039/d2fo00165a · Cited by 57 · see citing works

Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota

Gan, Q., Peng, M., Wei, H., Chen, L., Chen, X.-Y., Li, Z.-H., An, G., & Ma, Y. (2024) · Food & Function · doi:10.1039/d3fo05169b · Cited by 57 · see citing works

Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson’s Disease: The Role of Gut Microbiota and MicroRNAs

Lee, Y. Z., Cheng, S.-H., Chang, M.-Y., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076794 · Cited by 54 · see citing works

Updates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus

Un-Nisa, A., Khan, A., Zakria, M., Siraj, S., Ullah, S., Tipu, M. K., Ikram, M. A., & Kim, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010142 · Cited by 60 · see citing works

Engineered bacterial extracellular vesicles for central nervous system diseases

Ji, N., Wang, F., Wang, M., Zhang, W. C., Liu, H., & Su, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.027 · Cited by 52 · see citing works

The effects of heavy metal exposure on brain and gut microbiota: A systematic review of animal studies

Porru, S., Esplugues, A., Llop, S., & Delgado-Saborit, J. M. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123732 · Cited by 52 · see citing works

Advancements in Lactiplantibacillus plantarum : probiotic characteristics, gene editing technologies and applications

Zhang, Z., Niu, H., Qu, Q., Guo, D., Wan, X., Yang, Q., Mo, Z., Tan, S., Xiang, Q., Xue, T., et al. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2448562 · Cited by 57 · see citing works

Lactobacillus plantarum PS128 and Other Probiotics in Children and Adolescents with Autism Spectrum Disorder: A Real-World Experience

Mensi, M. M., Rogantini, C., Marchesi, M., Borgatti, R., & Chiappedi, M. A. (2021) · Nutrients · doi:10.3390/nu13062036 · Cited by 51 · see citing works

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota

Zhang, Y., Xu, S., Qian, Y., Mo, C., Ai, P., Yang, X., & Xiao, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1099018 · Cited by 49 · see citing works

Gut microbiota: a promising new target in immune tolerance

Almansour, N., Al‐Rashed, F., Choudhry, K., Alqaderi, H. E., Sindhu, S. T. A. K., Al‐Mulla, F., & Ahmad, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1607388 · Cited by 46 · see citing works

Microbiome-based therapies for Parkinson’s disease

Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1496616 · Cited by 46 · see citing works

Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate

Avagliano, C., Coretti, L., Lama, A., Pirozzi, C., Caro, C. D., Biase, D. D., Turco, L., Mollica, M. P., Paciello, O., Calignano, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126367 · Cited by 39 · see citing works

The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial

Mehrabani, S., Khorvash, F., Heidari, Z., Ebrahimi, M. T., & Amani, R. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105397 · Cited by 38 · see citing works

Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature

Beltrán-Velasco, A. I., Reiriz, M., Uceda, S., & Echeverry‐Alzate, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053010 · Cited by 38 · see citing works

Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights

Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 39 · see citing works

The Survival of Psychobiotics in Fermented Food and the Gastrointestinal Tract: A Review

Cichońska, P., Kowalska, E., & Ziarno, M. (2023) · Microorganisms · doi:10.3390/microorganisms11040996 · Cited by 39 · see citing works

Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases

Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 38 · see citing works

The Role of Nutraceuticals and Functional Foods in Mitigating Cellular Senescence and Its Related Aspects: A Key Strategy for Delaying or Preventing Aging and Neurodegenerative Disorders

Ristori, S., Bertoni, G., Bientinesi, E., & Monti, D. (2025) · Nutrients · doi:10.3390/nu17111837 · Cited by 41 · see citing works

Efficacy of probiotic supplements on Parkinson's disease: A systematic review and meta-analysis

Jin, X., Dong, W., Chang, K., Yan, Y., & Liu, X. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103045 · Cited by 35 · see citing works

A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease

Aktaş, B., Aslım, B., & Özdemir, D. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-65061-w · Cited by 37 · see citing works

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases

Bi, M., Liu, C., Wang, Y., & Liu, S. (2023) · Microorganisms · doi:10.3390/microorganisms11061527 · Cited by 34 · see citing works

Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review

Uceda, S., Echeverry‐Alzate, V., Reiriz, M., Miguel, E. M., Pérez-Curiel, A., Gómez-Senent, S., & Beltrán-Velasco, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713294 · Cited by 35 · see citing works

Emerging insights between gut microbiome dysbiosis and Parkinson’s disease: Pathogenic and clinical relevance

Bi, M., Feng, L., He, J., Liu, C., Wang, Y., Jiang, H., & Liu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101759 · Cited by 32 · see citing works

Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease

Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Food & Function · doi:10.1039/d2fo03825k · Cited by 32 · see citing works

A Combinational Therapy for Preventing and Delaying the Onset of Alzheimer’s Disease: A Focus on Probiotic and Vitamin Co-Supplementation

Sultana, O. F., Hia, R. A., & Reddy, P. H. (2024) · Antioxidants · doi:10.3390/antiox13020202 · Cited by 31 · see citing works

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson's disease model mice

Wang, L., Li, S., Jiang, Y., Zhao, Z., Shen, Y., Zhang, J., & Zhao, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104635 · Cited by 30 · see citing works

Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements

Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Saharan, B. S., Harshita, Duhan, J. S., & Gökşen, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300461 · Cited by 30 · see citing works

Efficacy of Probiotics in Improving Motor Function and Alleviating Constipation in Parkinson’s Disease: A Randomized Controlled Trial

Ghalandari, N., Assarzadegan, F., Habibi, S. A. H., Esmaily, H., & Malekpour, H. (2023) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-137840 · Cited by 28 · see citing works

Food, Health, and Environmental Impact of Lactic Acid Bacteria: The Superbacteria for Posterity

Akpoghelie, P. O., Edo, G. I., Mafe, A. N., Isoje, E. F., Igbuku, U. A., Ali, A. B. M., Yousif, E. A., Owheruo, J. O., Oberhiri, S. O., Essaghah, A. E. A., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10546-x · Cited by 28 · see citing works

Lactobacillus plantarum WSJ-06 alleviates neurobehavioral injury induced by lead in mice through the gut microbiota

Li, Y., Liu, A., Chen, L., Xiang, Y., Huang, D., Huang, W., Chen, Z., Fan, H., & Meng, X. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113308 · Cited by 26 · see citing works

Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1G93A Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis

Xin, Z., Xin, C., Huo, J., Liu, Q., Dong, H., Li, R., & Liu, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03988-x · Cited by 25 · see citing works

Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent

Aktaş, B. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01319-7 · Cited by 23 · see citing works

The link between the gut microbiome, inflammation, and Parkinson’s disease

Nie, S., & Ge, Y. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12789-6 · Cited by 23 · see citing works

Probiotic intervention in young children with autism spectrum disorder in Taiwan: A randomized, double-blinded, placebo-controlled trial

Liu, Y.-W., Wang, J.-E., Sun, F., Huang, Y., & Chen, H.-J. (2023) · Research in Autism · doi:10.1016/j.rasd.2023.102256 · Cited by 23 · see citing works

Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease

Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206157 · Cited by 23 · see citing works

Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease Mice Model

Liu, X., Du, Z.-R., Wang, X., Luk, K.-H., Chan, C.-H., Cao, X., Zhao, Q. S., Zhao, F., Wong, W., Wong, K., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.649627 · Cited by 22 · see citing works

Lactiplantibacillus plantarum PS128 Alleviates Exaggerated Cortical Beta Oscillations and Motor Deficits in the 6-Hydroxydopamine Rat Model of Parkinson’s Disease

Ma, Y.-F., Lin, Y.-A., Huang, C.-L., Hsu, C.-C., Wang, S. Z., Yeh, S., & Tsai, Y.-C. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09828-x · Cited by 22 · see citing works

Advanced Bioinspired Multifunctional Platforms Focusing on Gut Microbiota Regulation

Li, M., Wang, L., Lin, D., Liu, Z., Wang, H., Yang, Y., Sun, C., Ye, J., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c05013 · Cited by 22 · see citing works

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works

Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease

Cui, C., Song, H., Han, Y., Yu, H., Li, H., Yang, Y., & Zhang, B. (2023) · mSphere · doi:10.1128/msphere.00431-23 · Cited by 21 · see citing works

Oral Administration of Lactobacillus Inhibits the Permeability of Blood-Brain and Gut Barriers in a Parkinsonism Model

Nápoles-Medina, A. Y., Aguilar‐Uscanga, B. R., Solís-Pacheco, J. R., Tejeda-Martínez, A. R., Ramírez-Jirano, L. J., Urmeneta-Ortíz, M. F., Chaparro-Huerta, V., & Flores-Soto, M. E. (2023) · Behavioural Neurology · doi:10.1155/2023/6686037 · Cited by 21 · see citing works

5-HT4 Receptor is Protective for MPTP-induced Parkinson’s Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota

Cui, C., Shi, Y. W., Hong, H., Zhou, Y., Qiao, C.-M., Zhao, L., Jia, X.-B., Zhao, W., & Shen, Y. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10085-8 · Cited by 20 · see citing works

Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota

Liu, J., Zhang, Y., Ye, T., Yu, Q., Yu, J., Yuan, S., Gao, X., Wan, X., Zhang, R., Han, W., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06998 · Cited by 20 · see citing works

Neuroprotective Effects of Heat-Killed Levilactobacillus Brevis Ku15152 on H2o2-Induced Oxidative Stress

Bock, H.-J., Lee, N., & Paik, H. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2304.04045 · Cited by 20 · see citing works

Lactobacillus reuteri-derived γ-amino butyric acid alleviates MPTP-induced Parkinson’s disease through inhibiting ferroptosis via the AKT-GSK3β-GPX4 axis

Dong, X., Yang, T., & Jin, Z. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01022-y · Cited by 18 · see citing works

The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review

Panaitescu, P.-Ș., Răzniceanu, V., Mocrei-Rebrean, Ș.-M., Neculicioiu, V. S., Dragoș, H.-M., Costache, C. A., & Filip, G. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050244 · Cited by 18 · see citing works

Psychobiotic Properties of Lactiplantibacillus plantarum in Neurodegenerative Diseases

Chiano, M. D., Sallustio, F., Fiocco, D., Rocchetti, M. T., Spano, G., Pontrelli, P., Moschetta, A., Gesualdo, L., Gadaleta, R. M., & Gallone, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179489 · Cited by 20 · see citing works

Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases

Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 19 · see citing works

Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response

Işık, M., Köse, F., Özbayer, C., Budak, Ö., KELEŞ, R., Güzel, D., Demirci, M. A., Doğanay, S., & Bağcı, C. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10470-0 · Cited by 19 · see citing works

Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1α

Dong, Y., Qi, Y., Chen, J., Han, S., Su, W., Ma, X., Yu, Y., & Wang, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04038-2 · Cited by 18 · see citing works

Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects

Rojo, N. D., Blanco-Benítez, M., Cava, R., Fuentes, J. M., Canales-Cortés, S., & González‐Polo, R. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111629 · Cited by 17 · see citing works

Fucosylated Chondroitin Sulfate against Parkinson’s Disease through Inhibiting Inflammation Induced by Gut Dysbiosis

Liu, Y., Liu, X., Ye, Q., Wang, Y., Zhang, J., Lin, S., Wang, G., Yang, X., Zhang, J., Chen, S., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06429 · Cited by 16 · see citing works

Parkinson Disease and the Gut: A Primer for Gastroenterologists

Sharma, A., Voigt, R. M., Goetz, C. G., & Keshavarzian, A. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003508 · Cited by 16 · see citing works

Microbiota- Brain-Gut-Axis Relevance to Parkinson’s Disease: Potential Therapeutic Effects of Probiotics

Raj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 16 · see citing works

Parkinson’s Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration

Xiromerisiou, G., Marogianni, C., Androutsopoulou, A., Ntavaroukas, P., Mysiris, D. S., & Papoutsopoulou, S. (2023) · Biology · doi:10.3390/biology12010093 · Cited by 17 · see citing works

Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders

Gupta, S., Dinesh, S., & Sharma, S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249271548231115071021 · Cited by 16 · see citing works

Lactiplantibacillus plantarum SG5 inhibits neuroinflammation in MPTP-induced PD mice through GLP-1/PGC-1α pathway

Qi, Y., Dong, Y., Chen, J., Xie, S., Ma, X., Yu, X., Yu, Y., & Wang, Y. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115001 · Cited by 17 · see citing works

Low and high doses of oral maslinic acid protect against Parkinson’s disease via distinct gut microbiota-related mechanisms

Cao, X., Du, Z.-R., Liu, X., Wang, X., Li, C., Zhou, S.-N., Liu, J.-R., Xu, P.-Y., Ye, J.-L., Zhao, Q., et al. (2023) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2023.115100 · Cited by 15 · see citing works

Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson’s Disease

Radisavljevic, N., Cirstea, M. S., Bauer, K. C., Lo, C., Metcalfe‐Roach, A., Bozorgmehr, T., Bar‐Yoseph, H., & Finlay, B. B. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223165 · Cited by 14 · see citing works

The potential beneficial effects of Lactobacillus plantarum GM11 on rats with chronic unpredictable mild stress- induced depression

Ma, J., Wang, J., Wang, G., Wan, Y., Li, N., Luo, L., Gou, H., & Gu, J. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2205742 · Cited by 14 · see citing works

Exploring the role of gut microbiota in Parkinson’s disease: insights from fecal microbiota transplantation

Guo, M., Gao, H., Wang, Y., & Xiang, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1574512 · Cited by 13 · see citing works

Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review

El‐Saadony, M. T., Saad, A. M., Sitohy, M. Z., Alkafaas, S. S., Dladla, M., Ghosh, S., Mohammed, D. M., Ibrahim, E. H., Fahmy, M. A., Elkelish, A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713426 · Cited by 13 · see citing works

Phenotypic screening of novel probiotics with potential anti-neuroinflammation activity based on cell and zebrafish models

He, B., Hu, T., & Wu, H. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102949 · Cited by 11 · see citing works

Psychobiotic potential of Lactiplantibacillus plantarum: Current perspective in neurodegeneration and geriatric therapies

Gupta, N., Agarwal, A. K., Al-Dossari, M., & El-Gawaad, N. S. A. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100038 · Cited by 11 · see citing works

The combined use of B vitamins and probiotics promotes B vitamin absorption and increases Akkermansia abundance

Sang, L., Yang, S., Zhu, Y., Zhu, Z., Yang, B., Li, Z., Mao, X., Chen, S., Li, C., Du, J. C., et al. (2024) · Food & Function · doi:10.1039/d4fo01805b · Cited by 11 · see citing works

Gut-directed therapy in Parkinson’s disease

Benvenuti, L., Salvo, C. D., Bellini, G., Seguella, L., Rettura, F., Esposito, G., Antonioli, L., Ceravolo, R., Bernardini, N., Pellegrini, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407925 · Cited by 13 · see citing works

The role of the gut microbiota in neuropsychiatric disorders and therapy

Zhang, F., Ding, K., Zhang, L., Liu, D., Dong, X., Wang, M., Zhou, F.-L., Sun, Y., Zhang, W., Yu, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102894 · Cited by 11 · see citing works

Neuroprotective effect of thiamine-producing lactic acid bacteria in a murine Parkinsonian model

Terán, M. D. M., Visñuk, D. P., de Giori, G. S., de LeBlanc, A. D. M., & LeBlanc, J. G. (2022) · Food & Function · doi:10.1039/d2fo01195f · Cited by 11 · see citing works

Gut-oriented disease modifying therapy for Parkinson's disease

Lin, C., Lai, H., & Wu, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.09.010 · Cited by 11 · see citing works

Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective

Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 10 · see citing works

Clinical Application Value of Lactobacillus Plantarum PS128 in Patients with Anxiety Disorders

Meng, X., Gao, Y., Qi, H., Ding, Y., & Sun, Y. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.3.560 · Cited by 10 · see citing works

Prebiotics and probiotics and Parkinson's disease

Amani, R., & Mehrabani, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00034-2 · Cited by 9 · see citing works

A narrative review of research advances in gut microbiota and microecological agents in children with attention deficit hyperactivity disorder (ADHD)

Liu, Y., Zhang, P., & Sun, H. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1588135 · Cited by 9 · see citing works

Blastocystis: view from atop the gut–brain iceberg

Leonardi, S. S., & Tan, K. S. W. (2023) · Trends in Parasitology · doi:10.1016/j.pt.2023.10.002 · Cited by 9 · see citing works

Gut microbiota: the indispensable player in neurodegenerative diseases

Li, S., Cai, Y., Wang, S., Luo, L., Zhang, Y., Huang, K., & Guan, X. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13509 · Cited by 11 · see citing works

Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson's disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis

Li, T., Zhang, C., Wang, Q., Shuan, W., Yu, L., Zhai, Q., & Tian, F. (2024) · eFood · doi:10.1002/efd2.156 · Cited by 8 · see citing works

Intestinal microbiota distribution and changes in different stages of Parkinson's disease: A meta-analysis, bioinformatics analysis and in vivo simulation

Jiang, T., Wang, Y., Fan, W., Lu, Y., Zhang, G., Li, J., Ma, R., Liu, M., & Shi, J. (2025) · BioScience Trends · doi:10.5582/bst.2024.01352 · Cited by 8 · see citing works

Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson’s Disease: A Review and Mechanistic Insights

Chen, W.-L., Deng, F.-S., & Tsai, Y.-C. (2025) · Nutrients · doi:10.3390/nu17193047 · Cited by 6 · see citing works

Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson’s Disease: The Role of Gut Microbiota and MicroRNAs

Lee, Y. Z., Cheng, S.-H., Chang, M.-Y., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076794 · Cited by 54 · see citing works

Lactobacillus taiwanensis BCRC17755 alleviates motor dysfunction and dopaminergic neuronal loss in mouse models of Parkinson’s disease

Choi, Y.-C., Choi, J. G., Huh, E., Eo, H., Shin, Y. J., Park, M. G., Kim, D., & Oh, M. S. (2025) · Beneficial Microbes · doi:10.1163/18762891-bja00066

Preventive Attenuation of MPTP-Induced Parkinson’s Disease-like Abnormalities by Lactiplantibacillus plantarum SHOU LAC-1 in Mice

Zhao, W., He, Y., Ma, H., Tu, D., Chen, J., Sun, Q., Peng, Y., An, Z., Pan, P., Wu, W., et al. (2026) · Foods · doi:10.3390/foods15173116

<i>Lactobacillus plantarum</i> DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson’s Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder

Wang, L., Zhao, Z., Zhao, L., Zhao, Y., Yang, G., Wang, C., Gao, L., Niu, C., & Li, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07711 · Cited by 203 · see citing works